HOWARD MENIKOFF

Allopathic & Osteopathic Physicians|Allergy & Immunology NEW YORK, NY NPI 1720168529

General Payments — all program years on this page

$7,424.08

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 167
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $882.40 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $882.4020

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $1,323.9225
2019 $1,686.3437
2020 $577.9816
2021 $1,077.2526
2022 $1,211.1825
2023 $665.0118
2024 $882.4020

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1105285689 AstraZeneca Pharmaceuticals LP $125.00 06/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111650448 Amgen Inc. $77.62 02/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114114093 Regeneron Healthcare Solutions, Inc. $25.54 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114114095 Regeneron Healthcare Solutions, Inc. $20.96 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114114097 Regeneron Healthcare Solutions, Inc. $24.55 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114114099 Regeneron Healthcare Solutions, Inc. $24.48 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114114101 Regeneron Healthcare Solutions, Inc. $24.63 11/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114402667 Regeneron Pharmaceuticals, Inc. $116.74 10/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116276984 GlaxoSmithKline, LLC. $22.27 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117472872 BioCryst US Sales Co., LLC $69.85 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124741960 Grifols USA, LLC $17.73 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124741962 Grifols USA, LLC $19.00 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127906218 Dermavant Sciences, Inc. $82.17 03/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134649751 CSL Behring $108.41 12/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139628636 GENZYME CORPORATION $24.93 01/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139628686 GENZYME CORPORATION $23.60 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139628702 GENZYME CORPORATION $15.07 07/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139628724 GENZYME CORPORATION $15.07 09/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139628767 GENZYME CORPORATION $23.48 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152642633 LEO Pharma Inc. $21.30 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.